Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?
Plasmacytoid dendritic cells (pDCs) bridge innate and adaptive immune responses and
have important roles in hematopoietic engraftment, GvHD and graft-versus-leukemia
responses following allogeneic hematopoietic cell transplantation (HCT). In addition, pDCs
mediate antiviral immunity, particularly as they are the body's primary cellular source of type
I interferon. Given their pleiotropic roles, pDCs have emerged as cells that critically impact
transplant outcomes, including overall survival. In this article, we will review the pre-clinical …
have important roles in hematopoietic engraftment, GvHD and graft-versus-leukemia
responses following allogeneic hematopoietic cell transplantation (HCT). In addition, pDCs
mediate antiviral immunity, particularly as they are the body's primary cellular source of type
I interferon. Given their pleiotropic roles, pDCs have emerged as cells that critically impact
transplant outcomes, including overall survival. In this article, we will review the pre-clinical …
Abstract
Plasmacytoid dendritic cells (pDCs) bridge innate and adaptive immune responses and have important roles in hematopoietic engraftment, GvHD and graft-versus-leukemia responses following allogeneic hematopoietic cell transplantation (HCT). In addition, pDCs mediate antiviral immunity, particularly as they are the body’s primary cellular source of type I interferon. Given their pleiotropic roles, pDCs have emerged as cells that critically impact transplant outcomes, including overall survival. In this article, we will review the pre-clinical and clinical literature, supporting the crucial roles that pDCs assume as key immune effector cells during HCT.
nature.com